Drugs / ZFN Modified CD4+ T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02388594 | Apr 2015 → Sep 2018 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZFN Modified CD4+ T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02388594 ↗ |
| Modality | Cell therapy | “infused CCR5 gene-edited CD4+ T cells” PMID 33571163 ↗ Apr 2021 |
| Target | CCR5 | “CCR5 gene-edited CD4+ T cells” PMID 33571163 ↗ Apr 2021 |